NCT00150748View on ClinicalTrials.gov

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

PHASE3CompletedINTERVENTIONAL

Enrollment

217

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Generalized Epilepsy

Interventions

DRUG

Levetiracetam 166 mg

"* Active Substance: Levetiracetam~* Pharmaceutical Form: Tablet~* Concentration: 166 mg~* Route of Administration: Oral use"

DRUG

Levetiracetam 250 mg

"* Active Substance: Levetiracetam~* Pharmaceutical Form: Tablet~* Concentration: 250 mg~* Route of Administration: Oral use"

DRUG

Levetiracetam 500 mg

"* Active Substance: Levetiracetam~* Pharmaceutical Form: Tablet~* Concentration: 500 mg~* Route of Administration: Oral use"

All Listed Sponsors

lead

UCB Pharma SA

INDUSTRY

NCT00150748 - Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy | Biotech Hunter | Biotech Hunter